Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

How long does approval of a Hong Kong pharmaceutical licence usually take?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q467 · Category J: Cross-border pharmaceuticals and industry practice (Q451-Q500)
In general, the approval process for a Hong Kong pharmaceutical licence takes around 3 to 6 months, depending on the completeness and complexity of the application. If the documents are complete and meet the requirements, approval may be relatively quick; if further information is needed or an on-site inspection is conducted, the process may take longer. Compared with pharmaceutical registration in Mainland China, the Hong Kong process is simpler, but a reasonable amount of time should still be allowed. Applicants should prepare in advance and cooperate fully with the Drug Office’s review requirements.

📘 Regulatory basis

Guide to the approval process of the Drug Office, Department of Health, under the Pharmacy and Poisons Ordinance (Cap.138)

📗 Drew Tang's recommendations

We recommend that applicants allow sufficient time and submit complete documents early. Rengangyongsheng (Hong Kong) Limited can assist with following up on application progress.

📕 Risk notice

Incomplete information or repeated supplementary submissions can seriously delay approval and affect marketing plans.

Back to Category J: Cross-border Medicines and Industry Practice (Q451-Q500) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗